QCL-105329 (D0520C00021)

• Research type

  Research Study

• Full title

  An Exploratory Study to Assess the Absolute Bioavailability of a Single Oral Dose of AZD9668 with Respect to an Intra-venous Microdose of [14C]AZD9668 in Healthy Male Subjects

• IRAS ID

  53011

• Contact name

  Sharan Sidhu

• Sponsor organisation

  Quintiles Ltd

• Research summary

  AZD9668 is an investigational drug that has not yet been approved in any country to treat any medical conditions. It is being investigated as a treatment to control the symptoms and worsenings associated with chronic obstructive pulmonary disease (COPD). The purpose of this study is to measure the amount of AZD9668 in the blood when it is given by mouth as a tablet compared with intravenous (into a vein) administration.

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  10/IEC01/9

• Date of REC Opinion

  26 May 2010

• REC opinion

  Further Information Favourable Opinion